… the results achieved with sorafenib.6 Nevertheless, there remains … efficacy, and numerous trials are ongoing to explore … biological agents, or anti-cancer medications, (2) uncontrolled intercurrent … to the first dose of trial treatment, (5) active autoimmune …

… drugs, such as sorafenib, olaparib and bevacizumab, are a class of drugs … resistance of HCC cells to sorafenib [122]. Tumor-initiating … of HCC TIC to sorafenib [125]. Another study … US Food and Drug Administration (FDA) for the treatment of clinical …

… early-phase clinical trials as a mechanism … the Department of Medical Oncology and Therapeutics … All patients experienced treatment-emergent adverse effects … trial (NCT04723004), which evaluated first-line bevacizumab plus toripalimab vs sorafenib …

… as immunotherapies, targeted drugs, and novel … sorafenib in the landmark IMbrave150 trial, fundamentally shifting the treatment … advancing through clinical trials. Agents targeting the … -looking. For pharmaceutical companies, biotech firms, and investors …

… parallel-controlled, phase 3 APOLLO trial (NCT04344158) published in Lancet Oncology … effect on treatment exposure.” Investigators in the phase 3 trial randomly … #47;penpulimab and sorafenib groups, respectively, received local treatment for HCC, including …

… – Ivermectin synergizes sorafenib in hepatocellular carcinoma … Treatment?” was just published in the journal Acta Poloniae Pharmaceutica – Drug … large-scale clinical trials should be launched … doctor and compounded by a 50-state licensed pharmacy. Medication …

… clinical practice, the main medications used for MASLD include … being explored in clinical trials, they are still in … Sorafenib, a multi-targeted anticancer drug, is the first-line treatment … biological barriers to drug delivery. Nature Biotechnol. 2015;33(9 …

… compared with lenvatinib (Lenvima) or sorafenib (Nexavar) in patients with previously … at Kindai University Faculty of Medicine, as well as an executive … this trial, the FDA approved nivolumab plus ipilimumab in the first-line treatment …

… medications (ASMs) have been developed for epilepsy treatment.133 However, these drugs … with sorafenib: the checkmate 040 randomized clinical trial. JAMA … Cells Nanomed Biotechnol. 2018;46(8):2088 … Nose-to-Brain” drug delivery. Pharmaceutics. 2019;11(2):84 …

… targeted drugs.4 The TACTICS trial confirmed that TACE combined with sorafenib … Affiliated Hospital of Southwest Medical University and West China … Locoregional Treatment for Hepatocellular Carcinoma: possible Roles of Adjuvant Immunotherapy. Pharmaceutics. …